跳至主要内容
临床试验/IRCT201011025076N1
IRCT201011025076N1已完成2 期

Comparison of the efficacy of low dose topiramate and sodium valporate in migraine prophylaxis

Vice-chancellor for research, Ahvaz Jondishapour University of Medical Sciences and Health Services0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 45 years(—)
性别
Female

入选标准

  • Patient’s age between 20 and 45 years, discontinuation of other prophylactic drugs one month prior to study, interval between attacks more than 48 hours Exclusion criteria: pregnancy and breast feeding, non-migraine headaches, overuse of medications in migraine attacks (consumption of NSAID, Ergots & Triptans more than 8 days a month), substance and alcohol abuse, illiteracy of patients and their family (unable to fill diaries) minimal age:20 maximal age:45 sex:female

排除标准

  • 未提供

研究者

发起方
Vice-chancellor for research, Ahvaz Jondishapour University of Medical Sciences and Health Services

相似试验